Announcements Trials
Browse Landscape

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 18Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2232Neoplasms 2038Lung Neoplasms 1096Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 673Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Interventions

Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Observational × Anal Canal Carcinoma × Clear all
NCT04626466 2024-01-11

MIFADORESOL

Institut de cancérologie Strasbourg Europe

Completed
100 enrolled
GastrointestinalGenitourinaryGynecologic

Anal Canal Carcinoma, Uterine Cervical Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT03942900 2021-07-30

LAND

Centre Hospitalier Universitaire de Besancon

Withdrawn
Gastrointestinal

Anal Canal Carcinoma

NCT03465501 2018-03-14

BOOST-CA

Institut Paoli-Calmettes

Completed
89 enrolled
Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡